UnitedHealth Group's Share Price Plummets 46%: Is It Undervalued? UnitedHealth Group (UNH) has experienced a significant decline in its stock price, with a 46.3% drop over the past year. The stock recently closed at $269.54, reflecting a 5.6% decline in the last week, 7.1% over 30 days, and a 19.9% year-to-date drop. Investors are now questioning whether the company’s valuation has been overly adjusted or if the market has priced in too much pessimism. Analysts and valuation tools suggest the stock may be undervalued. A Discounted Cash Flow (DCF) analysis estimates the company’s intrinsic value at $816.71 per share, implying the current price is approximately 67% below this figure. This projection is based on UnitedHealth Group’s projected free cash flow of $27.8 billion in 2030, with estimates extending through 2035. The DCF model highlights a potential gap between the stock’s current price and its long-term cash flow potential. The company’s price-to-earnings (P/E) ratio of 20.29x also places it below industry and peer averages. The Healthcare sector’s average P/E is 21.22x, while the peer group average is 18.82x. A proprietary “Fair Ratio” calculation by Simply Wall St suggests a P/E of 37.06x, further indicating the stock may be undervalued relative to its growth prospects and risk profile. Investors are divided on the company’s future outlook, with differing narratives shaping valuation expectations. Some argue the stock could approach a Fair Value of $625 per share, while others suggest a lower range near $284. This divergence underscores how market perceptions and assumptions about revenue, earnings, and margins can lead to conflicting conclusions.#healthcare_sector #unitedhealth_group #discounted_cash_flow #simply_wall_st #free_cash_flow
